Profil
Christopher Bird worked as the Head of North American Medical & Scientific Affairs at Roche Diagnostics Corp.
He then served as the Chief Medical Officer at Bioporto A from 2019 to 2023.
Dr. Bird holds a doctorate degree from the University of Oxford and undergraduate degrees from Brigham Young University, London Business School, and Escuela Superior de Administración y Dirección de Empresas.
He also has a graduate degree from the University of California Los Angeles Graduate School.
Anciens postes connus de Christopher Bird
Sociétés | Poste | Fin |
---|---|---|
BIOPORTO A/S | Directeur Technique/Scientifique/R&D | 01/01/2023 |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Formation de Christopher Bird
Brigham Young University | Undergraduate Degree |
University of California Los Angeles Graduate School | Graduate Degree |
University of Oxford | Doctorate Degree |
London Business School | Undergraduate Degree |
Escuela Superior de Administración y Dirección de Empresas | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOPORTO A/S | Health Technology |
Entreprise privées | 1 |
---|---|
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |